🔎 Trials Near Me

Pradžia › Migrena › Oregon

Migrena klinikiniai tyrimai Oregon

6 tyrimai dėl Migrena ieško dalyvių vietose Oregon.

Miestai Oregon

Oficialus tyrimo tekstas (anglų kalba)

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • Providence Neuroscience Institute: Research Coordinators' Office, Portland
  • Providence Pediatric Specialty Clinic, Portland
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04743141

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Providence Neuroscience Institute - Research Coordinator's Office, Portland
  • Providence St. Vincent Medical Center, Portland
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04649242

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

  • Advanced Research Institute, Portland
Renkami dalyviai4 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-16 · NCT06972056

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Providence Brain and Spine Institute /ID# 231607, Portland
Renkami dalyviai3 fazė
Amžius nuo 6 iki 17 · Visoms lytims · Atnaujinta 2026-09-14 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • Summit Research Network, Portland
  • Advanced Research Institute - Portland, Portland
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-20 · NCT07645924

Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

  • Upsher-Smith Clinical Trial Site #6, Portland
  • Upsher-Smith Clinical Trials Site #7, Springfield
Renkami dalyviai4 fazė
Amžius nuo 6 iki 11 · Visoms lytims · Atnaujinta 2025-01-27 · NCT04748601

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.